(Q41589822)

4 October 2017

1 reference

title

Potential economic impact of glycoprotein IIb-IIIa inhibitors in improving outcomes of patients with acute ischemic coronary syndromes (English)

1 reference

4 October 2017

N E McElwee

1

1 reference

4 October 2017

E R Johnson

series ordinal

2

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

American Journal of Cardiology

4 October 2017

published in

1 reference

4 October 2017

volume

80

1 reference

4 October 2017

issue

4A

1 reference

4 October 2017

page(s)

39B-43B

1 reference

National health spending trends, 1960-1993

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Effectiveness in Health Care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Shattuck lecture--outcomes management. A technology of patient experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Unstable angina: cost of conservative and invasive strategies using TIMI3 B as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Operative risk assessment in coronary artery bypass surgery, 1990-1993: evaluation of perioperative variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Preoperative risk indicators of death at an early and late stage after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

A comparison of four severity-adjusted models to predict mortality after coronary artery bypass graft surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900576-6

10.1016/S0002-9149(97)00576-6

7 January 2021

Identifiers

DOI

1 reference

4 October 2017

1 reference